{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:18:50Z","timestamp":1790072330313,"version":"4.0.1"},"reference-count":48,"publisher":"American Psychiatric Association Publishing","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[1999,12,1]]},"DOI":"10.1176\/ajp.156.12.1871","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T15:36:40Z","timestamp":1659109000000},"page":"1871-1878","source":"Crossref","is-referenced-by-count":135,"title":["PET Imaging of Serotonin Type 2A Receptors in Late-Life Neuropsychiatric Disorders"],"prefix":"10.1176","volume":"156","author":[{"given":"Carolyn Cidis","family":"Meltzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester A.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil J.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Cantwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia R.","family":"Houck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit H.","family":"Mulsant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Ben-Eliezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lopresti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T.","family":"DeKosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Charles F.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R15612CHDEGHDH","doi-asserted-by":"crossref","unstructured":"Devanand D, Sano M, Tang M-X, Taylor S, Gurland B, Wilder D, Stern Y, Mayneux R: Depressed mood and the incidence of Alzheimer\u2019s disease in the elderly living in the community. Arch Gen Psychiatry 1996; 53:175\u2013182","DOI":"10.1001\/archpsyc.1996.01830020093011"},{"key":"R15612CHDHFHIC","doi-asserted-by":"crossref","unstructured":"Komahashi T, Ohmori K, Nakano T, Fujinuma H, Higashimoto T, Nakaya M, Kuroda J, Asahi H, Yoshikawa J, Mastumura S: Epidemiological survey of dementia and depression among the aged living in the community in Japan. Jpn J Psychiatry Neurol 1994; 48:517\u2013526","DOI":"10.1111\/j.1440-1819.1994.tb03009.x"},{"key":"R15612CHDFBEED","doi-asserted-by":"crossref","unstructured":"Arango V, Ernsberger P, Marzuk P, Chen J-S, Tierney H, Stanley M, Reis D, Mann J: Autoradiographic demonstration of increased serotonin 5-HT2 and \u03b2-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 1990; 47:1038\u20131047","DOI":"10.1001\/archpsyc.1990.01810230054009"},{"key":"R15612CHDGJAJI","doi-asserted-by":"crossref","unstructured":"Arora RC, Meltzer HY: Serotonergic measures in the brains of suicide victims:5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 1989; 146:730\u2013736","DOI":"10.1176\/ajp.146.6.730"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"McBride P, Brown R, DeMeo M, Keilp J, Mieczkowski T, Mann J: The relationship of platelet 5-HT2 receptor indices to major depressive disorder, personality traits, and suicidal behavior. Biol Psychiatry 1994; 35:295\u2013308","DOI":"10.1016\/0006-3223(94)90033-7"},{"key":"R15612CHDJAEFF","doi-asserted-by":"crossref","unstructured":"Cross AJ: Serotonin in Alzheimer-type dementia and other dementing illness. Ann NY Acad Sci 1990; 600:405\u2013417","DOI":"10.1111\/j.1749-6632.1990.tb16897.x"},{"key":"R15612CHDGAEJD","doi-asserted-by":"crossref","unstructured":"Cheng AVT, Ferrier IN, Morris CM, Jabeen S, Sahgal A, Mc\u00adKeith IG, Edwardson JA, Perry RH, Perry EK: Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer\u2019s and Parkinson\u2019s diseases. J Neurol Sci 1991; 106:50\u201355","DOI":"10.1016\/0022-510X(91)90193-B"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Bowen DM, Allen SJ, Benton JS, Goodhardt MJ, Haan EA, Palmer AM, Sims NR, Smith CCT, Spillane JA, Esiri MM, Neary D, Snowdon JS, Wilcock GK, Davison AN: Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer\u2019s disease. J Neurochem 1983; 41:266\u2013272","DOI":"10.1111\/j.1471-4159.1983.tb11838.x"},{"key":"R15612CHDCDIGH","unstructured":"Nordberg A: Neuroreceptor changes in Alzheimer disease. Cerebrovasc Brain Metab Rev 1992; 4:303\u2013328"},{"key":"R15612CHDCDGHA","doi-asserted-by":"crossref","unstructured":"Bowen DM, Najlerahim A, Procter A, Francis P, Murphy E: Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of late life. Proc Natl Acad Sci USA 1989; 86:9504\u20139508","DOI":"10.1073\/pnas.86.23.9504"},{"key":"R15612CHDBIADH","doi-asserted-by":"crossref","unstructured":"Blin J, Baron JC, Dubois B, Crouzel C, Fiorelli M, Attar-Levy D, Pillon B, Fournier D, Vidailhet M, Agid Y: Loss of brain 5HT2 receptors in Alzheimer\u2019s disease. Brain 1993; 116:497\u2013510","DOI":"10.1093\/brain\/116.3.497"},{"key":"R15612CHDJJEAB","doi-asserted-by":"crossref","unstructured":"Biver F, Wikler D, Lotstra F, Damhaut P, Goldman S, Mendlewicz J: Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br J Psychiatry 1997; 171:444\u2013448","DOI":"10.1192\/bjp.171.5.444"},{"key":"R15612CHDJCDGH","doi-asserted-by":"crossref","unstructured":"Marcusson J, Morgan D, Winblad B, Finch C: Serotonin-2 binding sites in human frontal cortex and hippocampus: selective loss of S-2A sites with age. Brain Res 1984; 311:51\u201356","DOI":"10.1016\/0006-8993(84)91397-0"},{"key":"atypb3","doi-asserted-by":"crossref","unstructured":"Cheetham S, Crompton M, Katona C, Horton R: Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res 1988; 443:272\u2013280","DOI":"10.1016\/0006-8993(88)91621-6"},{"key":"atypb4","doi-asserted-by":"crossref","unstructured":"Sparks D: Aging and Alzheimer\u2019s disease: altered cortical serotonergic binding. Arch Neurol 1989; 46:138\u2013140","DOI":"10.1001\/archneur.1989.00520380038010"},{"key":"atypb5","doi-asserted-by":"crossref","unstructured":"Gross-Isseroff R, Salama D, Isreli M, Biegon A: Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: effect of suicide. Brain Res 1990; 507:208\u2013215","DOI":"10.1016\/0006-8993(90)90274-F"},{"key":"R15612CHDGBEEA","doi-asserted-by":"crossref","unstructured":"Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J: Effect of aging in human cortical pre- and postsynaptic serotonin binding sites. Brain Res 1993; 620:163\u2013166","DOI":"10.1016\/0006-8993(93)90286-V"},{"key":"R15612CHDFEHDA","doi-asserted-by":"crossref","unstructured":"Meltzer CC, Smith G, Price JC, Reynolds CF III, Mathis CA, Greer P, Lopresti B, Mintun MA, Pollock BG, Ben-Eliezer D, Cantwell MN, Kaye W, DeKosky ST: Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction. Brain Res 1998; 813:167\u2013171","DOI":"10.1016\/S0006-8993(98)00909-3"},{"key":"R15612CHDFEEFH","doi-asserted-by":"crossref","unstructured":"Rosier A, Dupont P, Peuskens J, Bormanns G, Vandenberghe R, Maes M, de Groot T, Schiepers C, Verbruffen A, Mortelmans L: Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F] and positron emission tomographic imaging. Psychiatr Res 1996; 68:11\u201322","DOI":"10.1016\/S0925-4927(96)02806-5"},{"key":"R15612CHDFIGHH","doi-asserted-by":"crossref","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 1984; 34:939\u2013944","DOI":"10.1212\/WNL.34.7.939"},{"key":"R15612CHDCIEAH","doi-asserted-by":"crossref","unstructured":"Folstein MF, Folstein SE, McHugh PR: \u201cMini-Mental State\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189\u2013198","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"R15612CHDIFAAJ","doi-asserted-by":"crossref","unstructured":"Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56\u201362","DOI":"10.1136\/jnnp.23.1.56"},{"key":"R15612CHDCFJDG","unstructured":"Lemaire C, Cantineau R, Guillaume M, Plenevaux A, Christiaens L: Fluorine-18 altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats. J Nucl Med 1991; 32:2266\u20132272"},{"key":"R15612CHDEFDBH","doi-asserted-by":"crossref","unstructured":"Sandor S, Leahy R: Surface based labelling of cortical anatomy using a deformable atlas. IEEE Trans Med Imaging 1997; 16:41\u201354","DOI":"10.1109\/42.552054"},{"key":"R15612CHDBEGDE","doi-asserted-by":"crossref","unstructured":"Woods RP, Mazziotta JC, Cherry SR: MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993; 17:536\u2013546","DOI":"10.1097\/00004728-199307000-00004"},{"key":"R15612CHDGBCCF","doi-asserted-by":"crossref","unstructured":"D\u2019haenen H, Bossuyt A, Mertens J, Bossuyt-Piron C, Gijsemans M, Kaufman L: SPECT imaging of serotonin2 receptors in depression. Psychiatr Res Neuroimaging 1992; 45:227\u2013237","DOI":"10.1016\/0925-4927(92)90018-Y"},{"key":"R15612CHDIJFEH","doi-asserted-by":"crossref","unstructured":"Pazos A, Probst A, Palacios JM: Serotonin receptors in the human brain, IV: autoradiographic mapping of serotonin-2 receptors. Neuroscience 1987; 21:123\u2013139","DOI":"10.1016\/0306-4522(87)90327-7"},{"key":"R15612CHDFCDHG","doi-asserted-by":"crossref","unstructured":"Smith GS, Price JC, Lopresti BJ, Huang Y, Simpson N, Holt D, Mason NS, Meltzer CC, Sweet RA, Nichols T, Sashin D, Mathis CA: Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F] altanserin in the human brain. Synapse 1998; 30:380\u2013392","DOI":"10.1002\/(SICI)1098-2396(199812)30:4<380::AID-SYN5>3.3.CO;2-L"},{"key":"R15612CHDDCHCA","doi-asserted-by":"crossref","unstructured":"Logan J, Volkow N, Fowler J, Wang G-J, Dewey S, MacGregor R, Schlyer D, Gatley S, Pappas N, King P, Hitzemann R, Vitkun S: Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 1994; 14:995\u20131010","DOI":"10.1038\/jcbfm.1994.132"},{"key":"R15612CHDBABBF","doi-asserted-by":"crossref","unstructured":"Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, MacGregor RR, Hitzemann R, Bendriem B, Gatley SJ, Christman D: Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 1990; 10:740\u2013747","DOI":"10.1038\/jcbfm.1990.127"},{"key":"R15612CHDJFADB","doi-asserted-by":"crossref","unstructured":"Sadzot B, Lemaire C, Maquet P, Salmon E, Plenevaux A, Degueldre C, Hermanne J, Guillaume M, Cantineau R, Comar D, Franck G: Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls. J Cereb Blood Flow Metab 1995; 15:787\u2013797","DOI":"10.1038\/jcbfm.1995.99"},{"key":"R15612CHDGCDAA","doi-asserted-by":"crossref","unstructured":"Biver F, Goldman S, Luxen A, Monclus M, Forestini M, Mendlewicz J, Lotstra F: Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomography. Eur J Nucl Med 1994; 21:937\u2013946","DOI":"10.1007\/BF00238117"},{"key":"R15612CHDBGEBH","unstructured":"Chawluk JB, Alavi A, Dann R, Hurtig HI, Bais S, Kushner MJ, Zimmerman RA, Reivich M: Positron emission tomography in aging and dementia: effect of cerebral atrophy. J Nucl Med 1987; 28:431\u2013437"},{"key":"R15612CHDDJEIG","doi-asserted-by":"crossref","unstructured":"Erkinjuntti T, Lee DH, Gao F, Steenhuis R, Eliasziw M, Fry R, Merskey H, Hachinski VC: Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer\u2019s disease. Arch Neurol 1993; 50:305\u2013310","DOI":"10.1001\/archneur.1993.00540030069017"},{"key":"R15612CHDEEAGD","doi-asserted-by":"crossref","unstructured":"Alexopoulos G, Young R, Shindledecker R: Brain computed tomography findings in geriatric depression and primary degenerative dementia. Biol Psychiatry 1992; 31:591\u2013599","DOI":"10.1016\/0006-3223(92)90245-U"},{"key":"atypb7","doi-asserted-by":"crossref","unstructured":"Beats B, Levy R, Forstl H: Ventricular enlargement and caudate hyperdensity in elderly depressives. Biol Psychiatry 1991; 30:452\u2013458","DOI":"10.1016\/0006-3223(91)90306-7"},{"key":"R15612CHDGAIHC","doi-asserted-by":"crossref","unstructured":"Kumar A, Miller D, Ewbank D, Yousem D, Newberg A, Samuels S, Cowell P, Gottlieb B: Quantitative anatomic measures and comorbid medical illness in late-life major depression. Am J Geriatr Psychiatry 1997; 5:15\u201325","DOI":"10.1097\/00019442-199705010-00003"},{"key":"R15612CHDFAFEI","doi-asserted-by":"crossref","unstructured":"Meltzer CC, Leal JP, Mayberg HS, Wagner HJ, Frost JJ: Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J Comput Assist Tomogr 1990; 14:561\u2013570","DOI":"10.1097\/00004728-199007000-00011"},{"key":"R15612CHDIGIJF","doi-asserted-by":"crossref","unstructured":"Hrdina P, Demeter E, Vu T, Sotonyi P, Palkovits M:5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims\/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res 1993; 614:37\u201344","DOI":"10.1016\/0006-8993(93)91015-K"},{"key":"R15612CHDDBCFC","doi-asserted-by":"crossref","unstructured":"Biver F, Lotstra F, Monclus M, Wikler D, Damhaut P, Mendlewicz J, Goldman S: Sex difference in 5HT2 receptors in the living human brain. Neurosci Lett 1996; 204:25\u201328","DOI":"10.1016\/0304-3940(96)12307-7"},{"key":"atypb9","doi-asserted-by":"crossref","unstructured":"McBride P, Tierney H, DeMeo M, Chen J-S, Mann J: Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry 1990; 27:1143\u20131155","DOI":"10.1016\/0006-3223(90)90051-3"},{"key":"R15612CHDIADAH","unstructured":"Zhang L, Ma W, Barker J, Rubinow D: Sexual differences in mRNA expression and binding distribution of 5-HT1A and 5-HT2 receptors in rat hippocampus. Abstracts of the Society for Neuroscience 1994; 21:1548"},{"key":"R15612CHDEABGE","doi-asserted-by":"crossref","unstructured":"Gonzales G, Carillo C: Blood serotonin levels in postmenopausal women: effects of age and serum oestradiol levels. Maturitas 1993; 17:23\u201329","DOI":"10.1016\/0378-5122(93)90120-7"},{"key":"R15612CHDEDEDE","doi-asserted-by":"crossref","unstructured":"Crow TJ, Cross AJ, Cooper SJ, Deakin JF, Ferrier IN, Johnson JA, Joseph MH, Owen F, Poulter M, Lofthouse R, Corsellis J, Chambers D, Blessed G, Perry E, Perry R, Tomlinson B: Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 1984; 23:1561\u20131569","DOI":"10.1016\/0028-3908(84)90100-X"},{"key":"R15612CHDCBGHE","doi-asserted-by":"crossref","unstructured":"Cross AJ, Crow TJ, Ferrier IN, Johnson JA, Bloom SR, Corsellis JAN: Serotonin receptor changes in dementia of the Alzheimer type. J Neurochem 1984; 43:1574\u20131581","DOI":"10.1111\/j.1471-4159.1984.tb06081.x"},{"key":"R15612CHDBJBJH","doi-asserted-by":"crossref","unstructured":"Stockmeier C, Dilley G, Shapiro L, Overholser J, Thompson P, Meltzer H: Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology 1996; 16:162\u2013173","DOI":"10.1016\/S0893-133X(96)00170-4"},{"key":"atypb10","doi-asserted-by":"crossref","unstructured":"Owen F, Cross AJ, Crow TJ, Deakin JF, Ferrier IN, Lofthouse R, Poulter M: Brain 5-HT2 receptors and suicide (letter). Lancet 1983; 2:1256","DOI":"10.1016\/S0140-6736(83)91310-7"},{"key":"R15612CHDDEGCA","doi-asserted-by":"crossref","unstructured":"Owen F, Chambers DR, Cooper SJ, Crow TJ, Johnson JA, Lofthouse R, Poulter M: Serotonergic mechanisms in brains of suicide victims. Brain Res 1986; 362:185\u2013188","DOI":"10.1016\/0006-8993(86)91415-0"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ajp.psychiatryonline.org\/doi\/10.1176\/ajp.156.12.1871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:45:17Z","timestamp":1722386717000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.156.12.1871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12,1]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1999,12,1]]}},"alternative-id":["10.1176\/ajp.156.12.1871"],"URL":"https:\/\/doi.org\/10.1176\/ajp.156.12.1871","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,12,1]]}}}